Research crucial in determining what gene mutations might lead to congenital cardiovascular defects

NewsGuard 100/100 Score

According to the American Heart Association, congenital cardiovascular defects, such as congenital heart disease (CHD), are present in about one percent of live births and are the most common malformations in newborns.

A team of University of Pennsylvania School of Medicine researchers, led by Edward E. Morrisey, PhD, Associate Professor of Medicine, have been investigating how the heart develops from its earliest stages of development to its late stages, with the hope of learning why some hearts don't develop correctly. Dr. Morrisey's latest finding – to be published in the September 10th issue of Science – may redefine current models of how the heart develops in mammals. "Understanding the earliest steps in heart development gives us insight into the possible genetic causes of the dramatic heart defects exhibited by so many newborn babies, " says Morrisey.

During normal embryonic development in mammals, pre-cardiac cells form the bilateral cardiac primordia –two symmetrical, tube-shaped regions located on both sides of the early embryo. As cardiac development progresses, these two regions fuse, forming one large tube, which, in turn, further develops into the four-chamber heart.

Using genetically engineered mice, Penn researchers successfully inactivated the Foxp4 binding protein, which resulted in the inability of the bilateral tubes to fuse. They found that each region of pre-cardiac cells still developed into a single tube, and then further developed into a four-chamber heart. This resulted in the mouse embryos developing two, four-chambered hearts exhibiting most aspects of advanced heart development. Eventually these embryos succumbed due to the lack of correct blood flow with two hearts pumping into the same set of blood vessels.

Foxp4 belongs to a class of DNA binding proteins called transcription factors that turn other genes on and off. Interestingly, Foxp4 is not expressed in heart muscle cells themselves but rather in the primitive gut tube, which will develop into the stomach and intestines.

In the early mammalian embryo, the gut tube helps direct the fusion of the two tubes of pre-cardiac cells into one tube. Dr. Morrisey thinks that expression of Foxp4 in the gut tube may be responsible for this lack of fusion: "Other mutations in genes expressed in the gut tube have led to similar results in simpler organisms such as zebrafish. What is remarkable about Foxp4 mutant mice is that their hearts develop to such a late stage. We have never been able to determine in mammals whether fusion of the bilateral heart tubes was required for later stages of development including formation of all four-heart chambers. Now we know it's not necessary".

Another aspect of the work that is remarkable is that both of the hearts that form in Foxp4 mutant embryos show the same ability to distinguish left and right "sidedness". Many organs in the mammalian body have distinct left and right sides such as the heart and lung.

In Foxp4 mutant embryos, both hearts show the correct "sidedness" regardless of whether they were on the right or left side of the embryo.

The researchers suggest this work may be crucial in determining what gene mutations might lead to congenital cardiovascular defects. Cardiac development is conserved in mammals so defects in early cardiovascular development may lead to malformations in the human heart. "Although there have been no substantiated reports of humans born with two hearts, our understanding of how this very early process of fusion of the two bilateral cardiac primordial is regulated should provide a better understanding of many aspects of later heart development including those that are directly linked to congenital heart disease" says Morrisey.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Overdosing on chemo: A common gene test could save hundreds of lives each year